Is Sens stock a short squeeze opportunity?
The current consensus 12-month price target is around $2.17, but that’s a pretty steep drop from the $3 price at which SENS stock is trading now. As a short squeeze opportunity, SENS stock holds no appeal to me. That’s not my thing.
Should you hold senseonics (Sens) stock?
The consensus among Wall Street equities research analysts is that investors should "hold" Senseonics stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SENS, but not buy additional shares or sell existing shares. View analyst ratings for Senseonics or view top-rated stocks.
Is Sens a death Cross in the NASDAQ?
The one GOOD thing about SENS is that DIABETES is spreading faster than any other disease in America today. People younger and younger are succumbing to this disease. An analyst wrote on Friday calling a Death Cross in the Nasdaq.
Where can I buy SENs shares?
Shares of SENS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
Is Senseonics a buy right now?
2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last year. There are currently 2 buy ratings fo...
How were Senseonics' earnings last quarter?
Senseonics Holdings, Inc. (NYSEAMERICAN:SENS) released its quarterly earnings results on Tuesday, May, 10th. The company reported ($0.03) earnings...
What guidance has Senseonics issued on next quarter's earnings?
Senseonics updated its FY 2022 earnings guidance on Tuesday, May, 24th. The company provided earnings per share guidance of for the period. The com...
What price target have analysts set for SENS?
2 equities research analysts have issued 1 year target prices for Senseonics' shares. Their forecasts range from $4.00 to $6.00. On average, they e...
Who are Senseonics' key executives?
Senseonics' management team includes the following people: Dr. Timothy T. Goodnow , Pres, CEO & Director (Age 60, Pay $1.07M) Dr. Mukul Jain ,...
Who are some of Senseonics' key competitors?
Some companies that are related to Senseonics include Mesa Laboratories (MLAB) , Hurco Companies (HURC) , Crawford United (CRAWA) , Sypris Solu...
What other stocks do shareholders of Senseonics own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Senseonics investors own include VirnetX (VHC) , Advanced...
What is Senseonics' stock symbol?
Senseonics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SENS."
Who are Senseonics' major shareholders?
Senseonics' stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.44%), Vanguard...
Sign from God. Lol
Today is still a win
I'm at cvs getting my scripts 20 min ago. There was an old man over 70 infront of me driving me nuts he was so slow. But I held my cool and was nice. We both get up there. The lady says, I got your sensor no problem. I asked him what sensor. He said the g6. I said oh okay. Then he said, can't wait to switch.
How long does a Senseonics system last?
As everybody seems to be giving their 2 cents I may as well too. Today was disappointing because for all the hype, we didn't immediately see a jump in value. It seems we are back where we were a couple weeks ago. But the thing is we are not.
Is penny stock a compelling story?
This is an implanted system that lasts 90 days without replacing.
Is Senseonics worth the wait?
In fact, I think that as penny stocks go, it has a compelling story.
Is senseonomics a penny stock?
Senseonics has a compelling long-term story that may be worth the wait. On the other hand, it is, for now, one of the latest nails for retail investors who are looking to profit from a short squeeze. In my opinion, that’s unfortunate because at a lower price, and with less volatility, SENS stock has some appeal.
Does Chris Markoch have any positions in the securities mentioned in this article?
Senseonomics checked off a lot of those boxes. It is, and was, a penny stock that developed a high percentage of short interest. In other words, it had the ingredients for a sharp rise in price.
What is Senseonics diabetes monitor?
On the date of publication, Chris Markoch did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Does Brenden Rearick have any positions in the securities mentioned in this article?
Senseonics is a small, Maryland-based pharma company, which specializes in the development of products made to ease the burden of diabetes monitoring. Notably, the company is behind the only FDA approved long-term continuous glucose monitor, Eversense.
